Mirvetuximab Is a Promising Agent for Patients with Difficult-to-Treat Platinum-Resistant Ovarian CancerMarch 13th 2023
Emily Graham, PharmD, MS, BCOP, an Oncology Clinical Pharmacy Specialist at Allegheny Health Network in Pittsburg, Pennsylvania, discusses the potential outcomes of mirvetuximab for patients with platinum-resistant ovarian cancer.
Expert: Pharmacists Can Set Up EMRs to Default to the Best Treatment Per Payor With the Best Reimbursement RateMarch 10th 2023
Pharmacy departments can be one of the most expensive departments in a cancer center practice, but the revenue generated for its services typically far outpaces associated costs.
Social Determinants of Health Can Impact Vaccination Hesitancy, Appointment AdheranceMarch 9th 2023
John E. Clark, PharmD, MS, FASHP, FFSHP, Director, Diversity, Equity, and Inclusion at the Taneja College of Pharmacy, University of South Florida, discusses the importance of addressing social determinants of health to improve patient outcomes.
Expert: Bi-Enabled Technology in Radiation Oncology Is Shortening Time From Diagnosis to TreatmentMarch 9th 2023
Through automated tools related to scheduling, prior authorization, and radiation planning tasks, there are efforts to shorten the time from diagnosis to treatment to improve patient outcomes.